Valneva is a specialty vaccine company providing prevention against diseases with major unmet medical needs. The Company has a growing commercial business with two successful vaccines for travelers. Our focused pipeline includes the only Lyme disease vaccine candidate in clinical development today, a single-shot chikungunya vaccine candidate and an inactivated vaccine candidate against COVID-19.

Valneva at a glance

Successful commercial vaccines for travelers


Product sales revenues in 2019

Unique late stage vaccine programs


Travel vaccines

Vector-transmitted diseases


On prevention against diseases with major medical needs

> 500

employees in six countries